|
|
Article: Quintiles Backs Drug Discovery Transformation with Major Donation to Sage Bionetworks.
- Article from:
- Biotech Week
- Article date:
- October 21, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Sage Bionetworks, a not-for-profit organization established to develop an open-access genomic platform for use in drug discovery, announced a major founding donation today from Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide (see also Sage Bionetworks).
The Quintiles donation is a major facet of Sage's development efforts and will enable core research initiatives and development of the innovative Sage Commons platform.
Sage Bionetworks' initial work will include generating integrated databases, creating tools for building and mining disease models and ...